Keytruda Approved in China for Esophageal Squamous Cell Carcinoma Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter Keytruda is now approved in China for three different types of cancer. Source: Devices & Diagnostics Letter You Might Also Like Ridgeback Biotherapeutics to Launch Two Trials of Its COVID-19 Antiviral June 22, 2020 NIH and Novartis End Late-Stage Hydroxychloroquine Trials June 22, 2020 Gilead Sciences Gears Up for Clinical Trials of Inhaled Remdesivir June 22, 2020